Redefining Parameter Estimation and Covariate Selection via Variational Autoencoders : One Run Is All You Need

dc.contributor.authorRohleff, Jan
dc.contributor.authorBachmann, Freya
dc.contributor.authorNahum, Uri
dc.contributor.authorBräm, Dominic
dc.contributor.authorSteffens, Britta
dc.contributor.authorPfister, Marc
dc.contributor.authorKoch, Gilbert
dc.contributor.authorSchropp, Johannes
dc.date.accessioned2025-12-12T12:19:35Z
dc.date.available2025-12-12T12:19:35Z
dc.date.issued2025-12
dc.description.abstractGenerative Artificial Intelligence (AI) frameworks, such as Variational Autoencoders (VAEs), have proven powerful in learning structured representations from complex, high‐dimensional data. In pharmacometrics (PMX), nonlinear mixed effects (NLME) modeling is widely used to capture inter‐individual variability and link covariates to characterize parameters with the goal of informing key decisions in drug research and development. This research combines the strengths of both approaches by introducing a VAE framework specifically designed for NLME modeling. The proposed method integrates the flexibility of generative AI with the interpretability and robustness of mechanism‐based PMX modeling. To advance covariate selection in PMX, we replace the Evidence Lower Bound objective in VAEs with an objective function based on the corrected Bayesian information criterion. This enables the simultaneous evaluation of all potential covariate‐parameter combinations, thereby allowing for automated and joint estimation of population parameters and covariate selection within a single run. Manual selection and repeated model fitting across covariate combinations are no longer required. We demonstrate the effectiveness of this combined AI‐PMX approach with two representative cases. As the first generative AI‐based optimization method for NLME modeling, the VAE achieves high‐quality results in a single run, outperforming traditional stepwise procedures in terms of efficiency. As such, the presented approach facilitates automated model development, advancing PMX and its applications in model‐informed drug development.
dc.description.versionpublisheddeu
dc.identifier.doi10.1002/psp4.70129
dc.identifier.ppn1950437191
dc.identifier.urihttps://kops.uni-konstanz.de/handle/123456789/75473
dc.language.isoeng
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.ddc510
dc.titleRedefining Parameter Estimation and Covariate Selection via Variational Autoencoders : One Run Is All You Needeng
dc.typeJOURNAL_ARTICLE
dspace.entity.typePublication
kops.citation.bibtex
@article{Rohleff2025-12Redef-75473,
  title={Redefining Parameter Estimation and Covariate Selection via Variational Autoencoders : One Run Is All You Need},
  year={2025},
  doi={10.1002/psp4.70129},
  number={12},
  volume={14},
  issn={2163-8306},
  journal={CPT: Pharmacometrics & Systems Pharmacology},
  pages={2232--2243},
  author={Rohleff, Jan and Bachmann, Freya and Nahum, Uri and Bräm, Dominic and Steffens, Britta and Pfister, Marc and Koch, Gilbert and Schropp, Johannes}
}
kops.citation.iso690ROHLEFF, Jan, Freya BACHMANN, Uri NAHUM, Dominic BRÄM, Britta STEFFENS, Marc PFISTER, Gilbert KOCH, Johannes SCHROPP, 2025. Redefining Parameter Estimation and Covariate Selection via Variational Autoencoders : One Run Is All You Need. In: CPT: Pharmacometrics & Systems Pharmacology. Wiley. 2025, 14(12), S. 2232-2243. ISSN 2163-8306. eISSN 2163-8306. Verfügbar unter: doi: 10.1002/psp4.70129deu
kops.citation.iso690ROHLEFF, Jan, Freya BACHMANN, Uri NAHUM, Dominic BRÄM, Britta STEFFENS, Marc PFISTER, Gilbert KOCH, Johannes SCHROPP, 2025. Redefining Parameter Estimation and Covariate Selection via Variational Autoencoders : One Run Is All You Need. In: CPT: Pharmacometrics & Systems Pharmacology. Wiley. 2025, 14(12), pp. 2232-2243. ISSN 2163-8306. eISSN 2163-8306. Available under: doi: 10.1002/psp4.70129eng
kops.citation.rdf
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/75473">
    <dcterms:issued>2025-12</dcterms:issued>
    <dc:creator>Nahum, Uri</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/39"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/39"/>
    <dc:contributor>Steffens, Britta</dc:contributor>
    <dcterms:abstract>Generative Artificial Intelligence (AI) frameworks, such as Variational Autoencoders (VAEs), have proven powerful in learning structured representations from complex, high‐dimensional data. In pharmacometrics (PMX), nonlinear mixed effects (NLME) modeling is widely used to capture inter‐individual variability and link covariates to characterize parameters with the goal of informing key decisions in drug research and development. This research combines the strengths of both approaches by introducing a VAE framework specifically designed for NLME modeling. The proposed method integrates the flexibility of generative AI with the interpretability and robustness of mechanism‐based PMX modeling. To advance covariate selection in PMX, we replace the Evidence Lower Bound objective in VAEs with an objective function based on the corrected Bayesian information criterion. This enables the simultaneous evaluation of all potential covariate‐parameter combinations, thereby allowing for automated and joint estimation of population parameters and covariate selection within a single run. Manual selection and repeated model fitting across covariate combinations are no longer required. We demonstrate the effectiveness of this combined AI‐PMX approach with two representative cases. As the first generative AI‐based optimization method for NLME modeling, the VAE achieves high‐quality results in a single run, outperforming traditional stepwise procedures in terms of efficiency. As such, the presented approach facilitates automated model development, advancing PMX and its applications in model‐informed drug development.</dcterms:abstract>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/75473/1/Rohleff_2-j9qgj3iw0zwc6.pdf"/>
    <dc:contributor>Koch, Gilbert</dc:contributor>
    <dc:contributor>Nahum, Uri</dc:contributor>
    <dc:contributor>Rohleff, Jan</dc:contributor>
    <dc:creator>Steffens, Britta</dc:creator>
    <dc:contributor>Schropp, Johannes</dc:contributor>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/75473"/>
    <dc:contributor>Bachmann, Freya</dc:contributor>
    <dc:creator>Schropp, Johannes</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2025-12-12T12:19:35Z</dcterms:available>
    <dc:creator>Rohleff, Jan</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/75473/1/Rohleff_2-j9qgj3iw0zwc6.pdf"/>
    <dc:contributor>Bräm, Dominic</dc:contributor>
    <dc:creator>Pfister, Marc</dc:creator>
    <dcterms:title>Redefining Parameter Estimation and Covariate Selection via Variational Autoencoders : One Run Is All You Need</dcterms:title>
    <dc:creator>Bräm, Dominic</dc:creator>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2025-12-12T12:19:35Z</dc:date>
    <dc:contributor>Pfister, Marc</dc:contributor>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dc:language>eng</dc:language>
    <dc:creator>Koch, Gilbert</dc:creator>
    <dc:creator>Bachmann, Freya</dc:creator>
  </rdf:Description>
</rdf:RDF>
kops.description.funding{"first":"snsf","second":"10003647"}
kops.description.funding{"first":"snsf","second":"229140"}
kops.description.openAccessopenaccessgold
kops.flag.isPeerReviewedtrue
kops.flag.knbibliographytrue
kops.identifier.nbnurn:nbn:de:bsz:352-2-j9qgj3iw0zwc6
kops.sourcefieldCPT: Pharmacometrics & Systems Pharmacology. Wiley. 2025, <b>14</b>(12), S. 2232-2243. ISSN 2163-8306. eISSN 2163-8306. Verfügbar unter: doi: 10.1002/psp4.70129deu
kops.sourcefield.plainCPT: Pharmacometrics & Systems Pharmacology. Wiley. 2025, 14(12), S. 2232-2243. ISSN 2163-8306. eISSN 2163-8306. Verfügbar unter: doi: 10.1002/psp4.70129deu
kops.sourcefield.plainCPT: Pharmacometrics & Systems Pharmacology. Wiley. 2025, 14(12), pp. 2232-2243. ISSN 2163-8306. eISSN 2163-8306. Available under: doi: 10.1002/psp4.70129eng
relation.isAuthorOfPublicationd80441ba-5746-475c-b1df-3593e6132a87
relation.isAuthorOfPublication1d5a05fa-fb99-4245-b77e-181403e55446
relation.isAuthorOfPublication2782ff47-dd74-4851-80c2-af7e6d86c76b
relation.isAuthorOfPublication0a595ea2-787a-4f29-89e4-1df852a4e1cf
relation.isAuthorOfPublication0e1876e3-4b19-40a6-84fb-892cc5c830a8
relation.isAuthorOfPublication.latestForDiscoveryd80441ba-5746-475c-b1df-3593e6132a87
source.bibliographicInfo.fromPage2232
source.bibliographicInfo.issue12
source.bibliographicInfo.toPage2243
source.bibliographicInfo.volume14
source.identifier.eissn2163-8306
source.identifier.issn2163-8306
source.periodicalTitleCPT: Pharmacometrics & Systems Pharmacology
source.publisherWiley

Dateien

Originalbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
Rohleff_2-j9qgj3iw0zwc6.pdf
Größe:
1.01 MB
Format:
Adobe Portable Document Format
Rohleff_2-j9qgj3iw0zwc6.pdf
Rohleff_2-j9qgj3iw0zwc6.pdfGröße: 1.01 MBDownloads: 19